Aquestive Therapeutics Inc Capital Reinvestment Ratio
Aquestive Therapeutics Inc capital reinvestment ratio. Aquestive Therapeutics Inc (AQST) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($8.82 Million) in capital expenditures ($2.00K). See AQST FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Aquestive Therapeutics Inc (2017–2017)
Capital reinvestment ratio of Aquestive Therapeutics Inc from 2017 to 2017. This chart tracks Aquestive Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. See Aquestive Therapeutics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Aquestive Therapeutics Inc Capital Reinvestment Ratio by Year (2017–2017)
Aquestive Therapeutics Inc capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see AQST operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.36x | $5.82 Million | $2.07 Million | — |